Skip to main content

Lexeo Therapeutics, Inc.

LXEO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001907108

In the last 90 days, Lexeo Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 141 institutions reported holding it in 13F filings for Q2 2026, worth $410.9M in total; no superinvestor holds it.

13F holders, Q1 2024

Institutional positions in Lexeo Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
54
+23 vs. Q4 2023
Shares held
23.1M
+6.95M (+42.9%) vs. Q4 2023
Total value
$361.5M
+$144.5M (+66.5%) vs. Q4 2023
New holders
28
18 more added
Sold out
5
5 more reduced

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LXEO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 54 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 31 institutionsQ1 2024: 54 institutionsQ2 2024: 60 institutionsQ3 2024: 69 institutionsQ4 2024: 90 institutionsQ1 2025: 88 institutionsQ2 2025: 90 institutionsQ3 2025: 109 institutionsQ4 2025: 146 institutionsQ1 2026: 139 institutionsQ2 2026: 141 institutions
Value heldQ1 2024: $361.5M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $217.1MQ1 2024: $361.5MQ2 2024: $426.3MQ3 2024: $268.8MQ4 2024: $194.2MQ1 2025: $100.0MQ2 2025: $169.9MQ3 2025: $327.5MQ4 2025: $759.2MQ1 2026: $458.7MQ2 2026: $410.9M
Institutions holding LXEO and their total value by quarter
QuarterHoldersValue
Q2 2026141$410.9M
Q1 2026139$458.7M
Q4 2025146$759.2M
Q3 2025109$327.5M
Q2 202590$169.9M
Q1 202588$100.0M
Q4 202490$194.2M
Q3 202469$268.8M
Q2 202460$426.3M
Q1 202454$361.5M
Q4 202331$217.1M
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Lexeo Therapeutics, Inc.; share changes are against Q4 2023.

Institutions holding LXEO in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Eventide Asset Management, LLC3,369,147$52.8M0.83%+366,316+12.2%Added
Janus Henderson Group PLC2,540,785$39.8M0.02%+210,047+9.0%Added
D1 Capital Partners L.P.SuperinvestorD1 Capital Partners2,506,607$39.3M0.60%00.0%Unchanged
Citadel Advisors LLC2,502,981$38.9M0.04%+418,736+20.1%Added
Omega Fund Management, LLC2,355,904$36.9M23.83%+198,281+9.2%Added
Novo Holdings A/S1,638,298$25.7M1.77%+330,469+25.3%Added
Adage Capital Partners GP, L.L.C.1,322,736$20.7M0.04%+1,322,736New
Braidwell LP1,322,277$20.7M0.67%+1,322,277New
Artal Group S.A.801,716$12.6M0.32%+198,281+32.9%Added
Blackstone Group Inc.696,110$10.9M0.05%00.0%Unchanged
BlackRock Inc.662,962$10.4M0.00%+493,066+290.2%Added
Ra Capital Management, L.P.660,938$10.4M0.13%+660,938New
Millennium Management LLC593,722$8.73M0.01%+549,622+1,246.3%Added
Vanguard Group Inc481,755$7.55M0.00%+65,573+15.8%Added
Laurion Capital Management LP454,182$7.12M0.20%+198,881+77.9%Added
Geode Capital Management, LLC197,799$3.10M0.00%+97,378+97.0%Added
Vestal Point Capital, LP175,000$2.74M0.23%+175,000New
Cornell University126,258$1.98M30.03%+126,258New
State Street Corp112,215$1.76M0.00%+112,215New
Bank of Montreal111,186$1.75M0.00%+111,186New
Northern Trust Corp82,101$1.29M0.00%+66,512+426.7%Added
Verition Fund Management LLC60,843$954.0K0.01%−128,219−67.8%Reduced
Citigroup Inc49,177$771.1K0.00%−42,712−46.5%Reduced
Jane Street Group, LLC39,933$626.1K0.00%+973+2.5%Added
Bank of New York Mellon Corp28,323$444.1K0.00%+14,213+100.7%Added
Charles Schwab Investment Management Inc27,361$429.0K0.00%+27,361New
Goldman Sachs Group Inc23,559$369.4K0.00%+23,559New
Barclays PLC22,929$359.5K0.00%+7,412+47.8%Added
Jump Financial, LLC14,894$233.5K0.01%+14,894New
Renaissance Technologies LLC14,576$229.0K0.00%+14,576New
Morgan Stanley13,944$218.6K0.00%+4,456+47.0%Added
Nuveen Asset Management, LLC13,478$211.3K0.00%+13,478New
Woodline Partners LP12,051$189.0K0.00%+12,051New
Susquehanna International Group, LLP12,041$188.8K0.00%+12,041New
UBS Group AG10,367$162.6K0.00%+10,367New
Caxton Corp10,319$161.8K0.92%00.0%Unchanged
Rhumbline Advisers9,730$152.6K0.00%+9,730New
JPMorgan Chase & Co5,953$93.3K0.00%+5,841+5,215.2%Added
MetLife Investment Management5,821$91.3K0.00%+5,821New
Bank of America Corp5,271$82.6K0.00%−2,857−35.2%Reduced
American International Group, Inc.5,053$79.2K0.00%+5,053New
BNP Paribas Arbitrage, SA4,781$75.0K0.00%+4,781New
New York State Common Retirement Fund4,100$64.3K0.00%+4,100New
Wells Fargo & Company3,369$52.8K0.00%+3,297+4,579.2%Added
STRS Ohio1,800$28.0K0.00%+1,800New
California State Teachers Retirement System1,031$16.2K0.00%+1,031New
Ameritas Investment Partners, Inc.1,023$16.0K0.00%+1,023New
Legal & General Group Plc863$13.5K0.00%−14,137−94.2%Reduced
Amalgamated Bank623$10.0K0.00%+623New
Metropolitan Life Insurance Co599$9.39K0.00%+599New
Catalyst Funds Management Pty Ltd531$8.33K0.00%+531New
Tower Research Capital LLC (TRC)507$7.95K0.00%−983−66.0%Reduced
Royal Bank of Canada351$6.00K0.00%+351New
FMR LLC13$2040.00%+13New
ExodusPoint Capital Management, LP0$00.00%−34,172−100.0%Sold out
Point72 Middle East FZE0$00.00%−28,578−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−25,750−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−603−100.0%Sold out
Steward Partners Investment Advisory, LLC0$00.00%−323−100.0%Sold out